Condition
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Chronic Thromboembolic Pulmonary Hypertension (CTEPH) clinical trials that are recruiting, at sites in 3 countries (most in Switzerland (2), Russia (1), China (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 3Countries
Newest Chronic Thromboembolic Pulmonary Hypertension (CTEPH) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Levosimendan to see if it helps the heart after PEA in CTEPH | — | Novosibirsk | Recruiting | Nov 4, 2026 |
| Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease | — | Zurich, Canton of Zurich | Recruiting | Aug 20, 2026 |
| Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease | — | Zurich, Canton of Zurich | Recruiting | Aug 20, 2026 |
| Vasoactive Agents in Pulmonary Hypertension Crisis | — | Beijing, Beijing Municipality and 2 other locations | Recruiting | Jun 25, 2026 |
All recruiting trials (4)
-
Levosimendan to see if it helps the heart after PEA in CTEPH
This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.
-
Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease
This study tests whether using nasal liquid oxygen during a 6-minute walk test changes how far patients with PAH or CTEPH can walk compared to breathing room air.
-
Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease
This study tests whether walking with liquid oxygen at about 4 L/min helps or hinders distance walked compared with walking on room air in adults with PAH or CTEPH living in Switzerland.
-
Vasoactive Agents in Pulmonary Hypertension Crisis
This trial tests whether dopamine, norepinephrine, or epinephrine can safely and effectively help people with a pulmonary hypertension crisis who are in the hospital.
Related topics
Quick answers
How many Chronic Thromboembolic Pulmonary Hypertension (CTEPH) clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Switzerland (2 trials), Russia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.